Astera Labs (NASDAQ:ALAB) Research Coverage Started at Craig Hallum

Craig Hallum started coverage on shares of Astera Labs (NASDAQ:ALABFree Report) in a research report released on Monday, Marketbeat.com reports. The brokerage issued a buy rating and a $90.00 price target on the stock.

A number of other equities analysts have also recently weighed in on the stock. Jefferies Financial Group assumed coverage on shares of Astera Labs in a research report on Monday. They set a buy rating and a $85.00 price objective for the company. Morgan Stanley assumed coverage on shares of Astera Labs in a report on Monday. They issued an overweight rating and a $81.00 price objective on the stock. Needham & Company LLC assumed coverage on shares of Astera Labs in a research note on Monday. They set a buy rating and a $85.00 price target on the stock. Barclays assumed coverage on shares of Astera Labs in a research note on Monday. They set an overweight rating and a $85.00 price target on the stock. Finally, JPMorgan Chase & Co. initiated coverage on shares of Astera Labs in a research report on Monday. They set an overweight rating and a $85.00 price objective on the stock. Eleven equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company has an average rating of Buy and a consensus price target of $86.09.

Read Our Latest Stock Report on Astera Labs

Astera Labs Stock Performance

Astera Labs stock opened at $70.92 on Monday. Astera Labs has a 1-year low of $50.61 and a 1-year high of $95.21.

Insider Activity at Astera Labs

In other Astera Labs news, Director Jack R. Lazar bought 10,000 shares of the company’s stock in a transaction on Friday, March 22nd. The shares were bought at an average cost of $36.00 per share, with a total value of $360,000.00. Following the completion of the acquisition, the director now owns 165,000 shares of the company’s stock, valued at $5,940,000. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Hedge Funds Weigh In On Astera Labs

An institutional investor recently bought a new position in Astera Labs stock. Allspring Global Investments Holdings LLC acquired a new stake in shares of Astera Labs, Inc. (NASDAQ:ALABFree Report) in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 251,596 shares of the company’s stock, valued at approximately $18,666,000. Allspring Global Investments Holdings LLC owned approximately 0.16% of Astera Labs at the end of the most recent quarter.

Astera Labs Company Profile

(Get Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Read More

Analyst Recommendations for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.